Amphastar Pharmaceuticals
AMPH
AMPH
119 hedge funds and large institutions have $474M invested in Amphastar Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 42 increasing their positions, 49 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 23
91% less call options, than puts
Call options by funds: $32K | Put options by funds: $372K
Holders
119
Holding in Top 10
–
Calls
$32K
Puts
$372K
Top Buyers
| 1 | +$8.22M | |
| 2 | +$5.48M | |
| 3 | +$4.24M | |
| 4 |
BlackRock
New York
|
+$2.63M |
| 5 |
Renaissance Technologies
New York
|
+$1.97M |
Top Sellers
| 1 | -$3.18M | |
| 2 | -$2.62M | |
| 3 | -$2.3M | |
| 4 |
MCM
Matarin Capital Management
New York
|
-$1.96M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.42M |